Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

J&J submits sNDA for Invokana after premature end to clinical trial

pharmatimesApril 02, 2019

Tag: sNDA , J&J , Clinical Trial

PharmaSources Customer Service